Industry News
Pharmaceutical Industry News
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight esagonowsky Fri, 09/24/2021 - 09:44
AstraZeneca, Merck target broad use of Lynparza in prostate cancer as PARP rivals Pfizer, J&J, Clovis loom
AstraZeneca, Merck target broad use of Lynparza in prostate cancer as PARP rivals Pfizer, J&J, Clovis loom aliu Fri, 09/24/2021 - 09:34
Fierce Pharma Asia—Enhertu’s big win; Biogen-Samsung’s Lucentis biosimilar; Clover’s COVID vaccine data
Fierce Pharma Asia—Enhertu's big win; Biogen-Samsung's Lucentis biosimilar; Clover's COVID vaccine data aliu Fri, 09/24/2021 - 05:19
C.D.C. Panel Recommends Pfizer Boosters for Many Americans, but Not Health Workers
Scientific advisers to the C.D.C. also recommended the coronavirus vaccine boosters for those with certain medical conditions, but excluded those at risk because of their jobs.
CDMO Lonza strikes deal with Allarity Therapeutics to manufacture cancer drug candidate dovitinib
CDMO Lonza strikes deal with Allarity Therapeutics to manufacture cancer drug candidate dovitinib kdunleavy Thu, 09/23/2021 - 15:42
Takeda breached its contract with AbbVie by failing to supply prostate cancer drug Lupron, court rules
Takeda breached its contract with AbbVie by failing to supply prostate cancer drug Lupron, court rules kdunleavy Thu, 09/23/2021 - 11:27
Vaccine players in Argentina, Brazil selected as regional producers for COVID-19 shots
Vaccine players in Argentina, Brazil selected as regional producers for COVID-19 shots jkeenan Thu, 09/23/2021 - 09:55
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy nhigginsdunn Thu, 09/23/2021 - 09:52
Amid heated debate, FDA hands limited nod to Pfizer for COVID-19 vaccine boosters
Amid heated debate, FDA hands limited nod to Pfizer for COVID-19 vaccine boosters kdunleavy Thu, 09/23/2021 - 09:40
On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease
On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease aliu Thu, 09/23/2021 - 09:14
Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight
Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight esagonowsky Thu, 09/23/2021 - 09:08
Takeda breaks ground on $14M green building at Singapore manufacturing plant
Takeda breaks ground on $14M green building at Singapore manufacturing plant jkeenan Thu, 09/23/2021 - 08:47
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer’s drug Aduhelm
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer's drug Aduhelm nhigginsdunn Wed, 09/22/2021 - 16:46
Small but formidable activist investor Bluebell takes stake in GlaxoSmithKline, asks CEO Walmsley to reapply for job: FT
Small but formidable activist investor Bluebell takes stake in GlaxoSmithKline, asks CEO Walmsley to reapply for job: FT kdunleavy Wed, 09/22/2021 - 16:23
The unvaccinated are mostly young and non-political, a study finds. Time for pharma to switch up media outreach?
The unvaccinated are mostly young and non-political, a study finds. Time for pharma to switch up media outreach? nmissakian Wed, 09/22/2021 - 16:09
The unvaccinated are mostly young and nonpolitical, a study finds. Time for pharma to switch up media outreach?
The unvaccinated are mostly young and nonpolitical, a study finds. Time for pharma to switch up media outreach? nmissakian Wed, 09/22/2021 - 16:09
Pressure Grows on U.S. Companies to Share Covid Vaccine Technology
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.
Reckitt’s Mucinex ushers in cold and flu season with tribute to Latinos making a difference
Reckitt's Mucinex ushers in cold and flu season with tribute to Latinos making a difference bbulik Wed, 09/22/2021 - 13:07
Lonza’s march of manufacturing expansion continues with more backyard plans
Lonza's march of manufacturing expansion continues with more backyard plans jkeenan Wed, 09/22/2021 - 11:58
Play-by-play: How Sanofi jacked up its offer twice to seal the $1.9B deal for Kadmon
Play-by-play: How Sanofi jacked up its offer twice to seal the $1.9B deal for Kadmon aliu Wed, 09/22/2021 - 11:43